Wells Fargo’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,150
| Closed | -$18.9K | – | 7818 |
|
|
2023
Q4 | $18.9K | Sell |
1,150
-100
| -8% | -$1.57K | ﹤0.01% | 5654 |
|
|
2023
Q3 | $9.66K | Sell |
1,250
-10,000
| -89% | -$54.2K | ﹤0.01% | 5817 |
|
|
2023
Q2 | $58.6K | Buy |
11,250
+10,000
| +800% | +$51K | ﹤0.01% | 5353 |
|
|
2023
Q1 | $6.71K | Hold |
1,250
| – | – | ﹤0.01% | 5978 |
|
|
2022
Q4 | $4.64K | Hold |
1,250
| – | – | ﹤0.01% | 5795 |
|
|
2022
Q3 | $7K | Hold |
1,250
| – | – | ﹤0.01% | 5833 |
|
|
2022
Q2 | $8K | Hold |
1,250
| – | – | ﹤0.01% | 5861 |
|
|
2022
Q1 | $9K | Buy |
1,250
+1,150
| +1,150% | +$11.3K | ﹤0.01% | 6328 |
|
|
2021
Q4 | $1K | Sell |
100
-26
| -21% | -$430 | ﹤0.01% | 7111 |
|
|
2021
Q3 | $3K | Sell |
126
-41
| -25% | -$1.22K | ﹤0.01% | 6522 |
|
|
2021
Q2 | $7K | Hold |
167
| – | – | ﹤0.01% | 6253 |
|
|
2021
Q1 | $12K | Sell |
167
-9
| -5% | -$639 | ﹤0.01% | 6293 |
|
|
2020
Q4 | $7K | Hold |
176
| – | – | ﹤0.01% | 6100 |
|
|
2020
Q3 | $7K | Buy |
176
+106
| +151% | +$5.48K | ﹤0.01% | 5968 |
|
|
2020
Q2 | $4K | Hold |
70
| – | – | ﹤0.01% | 6034 |
|
|
2020
Q1 | $5K | Buy |
70
+31
| +79% | +$3.57K | ﹤0.01% | 5871 |
|
|
2019
Q4 | $5K | Buy |
+39
| New | +$4.74K | ﹤0.01% | 6051 |
|
Wells Fargo's ORTX Position: Q1 2024 in Review
Wells Fargo sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 1,150 shares — an estimated $18.9K sold.
Wells Fargo first reported a position in ORTX in Q4 2019 and held it in 17 quarters. The position peaked at $58.6K in Q2 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.
- Wells Fargo reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- Wells Fargo sold 1,150 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $18.9K.
- Wells Fargo first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 17 quarters.
- Wells Fargo's Orchard Therapeutics plc American Depositary Shares position peaked at $58.6K in Q2 2023.
- 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.
Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.